$213 Million is the total value of KNOTT DAVID M's 133 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 40.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UPLD | Buy | Upland Software, Inc. | $11,416,000 | +0.9% | 420,000 | +20.0% | 5.36% | +46.2% |
| MPLX | Buy | MPLX LP | $9,380,000 | -9.8% | 309,558 | +3.2% | 4.41% | +30.6% |
| FTAI | Buy | Fortress Trans & Infrastructure Inv. LLC | $8,261,000 | -9.3% | 576,064 | +15.0% | 3.88% | +31.4% |
| APO | Buy | Apollo Global Management LLC | $7,919,000 | +118.3% | 322,708 | +207.3% | 3.72% | +216.1% |
| LKQ | Buy | LKQ Corporation | $6,526,000 | +174.8% | 275,000 | +266.7% | 3.07% | +297.8% |
| MIK | Buy | The Michaels Companies, Inc. | $5,822,000 | +19.6% | 430,000 | +43.3% | 2.74% | +73.2% |
| TSG | New | The Star Group, Inc. | $3,997,000 | – | 241,920 | +100.0% | 1.88% | – |
| CLMT | Buy | Calumet Specialty Products Partners, LP | $3,390,000 | -63.7% | 1,534,031 | +5.2% | 1.59% | -47.4% |
| HHC | Buy | The Howard Hughes Corporation | $2,528,000 | -12.6% | 25,900 | +11.2% | 1.19% | +26.5% |
| BDSI | Buy | BioDelivery Sciences International, Inc. | $1,851,000 | +76.8% | 500,300 | +33.8% | 0.87% | +155.9% |
| VKTX | Buy | Viking Therapeutics, Inc. | $1,821,000 | -55.8% | 238,102 | +0.6% | 0.86% | -36.0% |
| NBL | New | Noble Energy, Inc. | $1,801,000 | – | 96,000 | +100.0% | 0.85% | – |
| ARNA | Buy | Arena Pharmaceuticals, Inc. | $1,551,000 | -10.1% | 39,828 | +6.2% | 0.73% | +30.2% |
| STML | Buy | Stemline Therapeutics, Inc. | $1,480,000 | -15.3% | 155,795 | +48.0% | 0.70% | +22.6% |
| EIGR | Buy | Eiger BioPharmaceuticals, Inc. | $1,334,000 | +10.4% | 131,333 | +30.5% | 0.63% | +59.9% |
| RDUS | Buy | Radius Health Inc. | $1,274,000 | +225.0% | 77,269 | +251.2% | 0.60% | +371.7% |
| AIMT | Buy | Aimmune Therapeutics, Inc. | $1,264,000 | +5.0% | 52,857 | +19.7% | 0.59% | +51.9% |
| CPRX | Buy | Catalyst Pharmaceuticals, Inc. | $1,178,000 | -43.7% | 613,447 | +10.8% | 0.55% | -18.4% |
| CNCE | Buy | Concert Pharmaceuticals, Inc. | $1,008,000 | +3.0% | 80,300 | +21.7% | 0.47% | +49.1% |
| XLRN | Buy | Acceleron Pharma, Inc. | $758,000 | -19.3% | 17,400 | +6.1% | 0.36% | +16.7% |
| FOMX | New | Foamix Pharmaceuticals Ltd. | $740,000 | – | 206,200 | +100.0% | 0.35% | – |
| KPTI | Buy | Karyopharm Therapeutics, Inc. | $337,000 | -38.2% | 36,000 | +12.5% | 0.16% | -10.7% |
| BLCM | Buy | Bellicum Pharmaceuticals, Inc. | $325,000 | -41.5% | 111,427 | +23.4% | 0.15% | -15.0% |
| DELL | New | Dell Technologies, Inc. | $314,000 | – | 6,426 | +100.0% | 0.15% | – |
| ALIM | Buy | Alimera Sciences, Inc. | $279,000 | -11.7% | 387,901 | +20.1% | 0.13% | +27.2% |
| New | Novartis AG | $257,000 | – | 3,000 | +100.0% | 0.12% | – | |
| FSBW | New | FS Bancorp Inc. | $154,000 | – | 3,577 | +100.0% | 0.07% | – |
| LEGH | New | Legacy Housing Corp | $108,000 | – | 9,000 | +100.0% | 0.05% | – |
| MEIP | Buy | MEI Pharma, Inc. | $102,000 | +12.1% | 38,590 | +83.8% | 0.05% | +60.0% |
| KRYS | New | Krystal Biotech, Inc. | $31,000 | – | 1,502 | +100.0% | 0.02% | – |
| New | Peoples United Financial | $22,000 | – | 1,500 | +100.0% | 0.01% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Ligand Pharmaceuticals Incorporated | 34 | Q3 2021 | 52.6% |
| Pfizer Inc. | 34 | Q3 2021 | 17.4% |
| Capitol Federal S&L | 34 | Q3 2021 | 5.7% |
| JP Morgan Chase& Co. | 34 | Q3 2021 | 1.3% |
| Apple Inc. | 34 | Q3 2021 | 2.1% |
| Microsoft Corporation | 34 | Q3 2021 | 2.3% |
| AllianceBernstein Holdings PL Unit Ltd. | 34 | Q3 2021 | 0.9% |
| Johnson & Johnson | 34 | Q3 2021 | 0.6% |
| Mondelez Int'lt Inc. | 34 | Q3 2021 | 0.5% |
| Ryman Hospitality PPTYS Inc. | 34 | Q3 2021 | 0.4% |
View KNOTT DAVID M's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| LIGAND PHARMACEUTICALS INC | February 13, 2018 | 865,500 | 4.1% |
| Rand Logistics, Inc. | November 15, 2017 | 1,432,660 | 7.2% |
| Essex Rental Corp. | August 16, 2013 | 1,124,472 | 4.5% |
| Westway Group, Inc. | February 01, 2013 | ? | ? |
| FutureFuel Corp. | February 01, 2012 | 1,838,000 | 4.5% |
| COLUMBIA LABORATORIES INC | January 31, 2012 | ? | ? |
| Essex Rental Corp. | February 16, 2011 | 2,805,666 | 13.0% |
| Pet DRx CORPSold out | February 09, 2011 | 0 | 0.0% |
| China Ceramics Co., Ltd | October 14, 2010 | 1,350,000 | 10.3% |
| NABI BIOPHARMACEUTICALS | June 22, 2010 | 2,344,597 | 4.8% |
View KNOTT DAVID M's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-13 |
| 13F-HR | 2021-05-13 |
| 13F-HR | 2021-02-12 |
| 13F-HR | 2020-11-13 |
| 13F-HR | 2020-08-12 |
| 13F-HR | 2020-05-13 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-12 |
| 13F-HR | 2019-08-12 |
View KNOTT DAVID M's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.